News

Filter

1 to 9 of 95897 results

Actavis confirms patent challenge for generic Neupro

23-08-2014

Ireland-headquartered generics major Actavis on Friday confirmed that it has filed an Abbreviated New…

ActavisGenericsLegalNeuproNeurologicalPatentsRegulationUCBUSA

Hera Therapeutics’ HTI-1968 shuts down HPV that causes most cervical cancer

23-08-2014

Research presented at the 29th Annual International Papillomavirus Conference shows that a therapy being…

Anti-viralsHera Therapeuticshti-1968PharmaceuticalResearchWomen's Health

Cubist's ceftolozane/ tazobactam accepted for Marketing Authorization Application review by EMA

Cubist's ceftolozane/ tazobactam accepted for Marketing Authorization Application review by EMA

22-08-2014

The European Medicines Agency has accepted for review a Marketing Authorization Application by American…

Antibiotics and Infectious diseasesceftolozaneComplicated intra-abdominal infectionsComplicated urinary tract infectionsCubist PharmaceuticalsEnterobacteriaEuropean Medicines AgencyGram-negative bacteriaPharmaceuticalRegulationtazobactamUSA

ViaCyte gets $20 million in deal with Janssen

ViaCyte gets $20 million in deal with Janssen

22-08-2014

Privately held US regenerative medicine company ViaCyte has entered into a rights agreement with Janssen…

BiotechnologyDiabetesEndocrine systemFinancialJanssenJohnson & JohnsonLicensingUSAVC-01ViaCyte

Mylan launches first generic Klor-Con extended-release tablets

Mylan launches first generic Klor-Con extended-release tablets

22-08-2014

US generic drugs major Mylan said today that it has launched potassium chloride extended-release tablets…

GenericsKlor-ConMarkets & MarketingMetabolicsMylanUpsher-SmithUSA

Wide-scale collaboration shows potential for innovation in animal testing

Wide-scale collaboration shows potential for innovation in animal testing

22-08-2014

Here's our take on the week's top stories.

Animal rightsAnimal testingClinical researchHealth Medical PharmaMedicines and Healthcare Products Regulatory AgencyPharmaceutical sciencesPharmacologyResearchScience

Call for Indian govt to bring more essential drugs under price control from NGOs

Call for Indian govt to bring more essential drugs under price control from NGOs

22-08-2014

Non-governmental organizations in India have jointly issued a letter calling on the country’s government…

Cardio-vascularDiabetesIndiaNational Pharmaceuticals Pricing AuthorityPharmaceuticalPoliticsPricing

EXPERT VIEW: Pay-for-delay - GSK’s wait is almost over…

EXPERT VIEW: Pay-for-delay - GSK’s wait is almost over…

22-08-2014

If GlaxoSmithKline thought that the demise of the Office of Fair Trading (OFT) on April 1 would bring…

Activist UK LimitedGenericsGlaxoSmithKlineLicensingPatentsPharmaceuticalSeroxatUK

1 to 9 of 95897 results

Back to top